Overalls

EQS-News: Mister Spex meets 2023 guidance, gains market share again and embarks on the next chapter of sustainable growth

Retrieved on: 
Wednesday, April 10, 2024
Spex, AOV, Growth, AI, Overalls, Video game

Mister Spex meets 2023 guidance, gains market share again and embarks on the next chapter of sustainable growth

Key Points: 
  • Mister Spex meets 2023 guidance, gains market share again and embarks on the next chapter of sustainable growth
    The issuer is solely responsible for the content of this announcement.
  • Mister Spex meets 2023 guidance, gains market share again and embarks on the next chapter of sustainable growth
    Adjusted EBITDA reached € 0.9 million, an improvement of approx.
  • The core market, Germany, has been the key driver behind the strong revenue growth in 2023.
  • Dirk Graber, CEO of Mister Spex SE says: “Mister Spex had a successful year in 2023 by growing market share and adjusted EBITDA despite challenging market conditions.

EQS-News: centrotherm international AG: Preliminary Group figures for 2023 confirm positive business development; Management Board examines strategic financing options to accelerate further growth

Retrieved on: 
Wednesday, April 10, 2024
EUR, Annual, Growth, Environment, Intelligence, Research, Overalls, Blaubeuren, Annual general meeting, Investment, Annual report, The Annual Report, Silicon, Management

centrotherm international AG: Preliminary Group figures for 2023 confirm positive business development; Management Board examines strategic financing options to accelerate further growth

Key Points: 
  • centrotherm international AG: Preliminary Group figures for 2023 confirm positive business development; Management Board examines strategic financing options to accelerate further growth
    The issuer is solely responsible for the content of this announcement.
  • centrotherm international AG: Preliminary Group figures for 2023 confirm positive business development; Management Board examines strategic financing options to accelerate further growth
    Blaubeuren, March 14, 2024 - centrotherm international AG today published preliminary, unaudited figures for the 2023 financial year in an ad hoc announcement.
  • In contrast, EBITDA is expected to reach the forecast of a positive EBITDA in the low double-digit million range at EUR 19 million.
  • Based on these positive preliminary business figures for 2023, the Executive Board believes that its strategy has been confirmed overall and has therefore decided today to examine strategic financing options.

Global Experts from SEPA Call for the Control of Gingivitis Rather than Waiting for Periodontitis to Develop

Retrieved on: 
Monday, April 8, 2024
CASA, Toothpaste, Head, Confusion, Tooth brushing, EFP, Journal of Clinical Periodontology, Patient, Quality of life, Complutense University of Madrid, UCM, Therapy, Dental, Oral hygiene, Etiology, United States of Europe, Risk, Education, Gingivitis, Treatment, Recurrence, Dentistry, Prevalence, Disease, Clinical, White paper, Public, Knowledge, Research, University, Overalls, University College London, Mouthwash, Dentist, Molina Healthcare, Health, Motivation, Incidence, Physician, British Dental Journal, Inflammation, Pharmacist, Plaque, Systematic review, Bleeding, S3, Meta-analysis

SEPA: Limited knowledge among oral health teams of the recommendations and evidence currently available on oral antiseptics (that are clinically proven to be effective) reduces their implementation; therefore, more practical and simple advice is proposed.

Key Points: 
  • This was highlighted at an International Summit of Experts held at the Casa de las Encías in Madrid, Spain, the headquarters of the SEPA Foundation.
  • "Periodontal diseases are prevalent worldwide, affecting hundreds of millions of people," says the meeting coordinator, Dr. Paula Matesanz, vice president of SEPA.
  • As Dr. Iain Chapple summarizes, "It is time for a paradigm shift: we must control gingivitis and not wait until periodontitis develops."
  • J Clin Periodontol 2022 Jun:49 Suppl 24:4-71 (version adapted by SEPA available at https://portal.guiasalud.es/gpc/tratamiento-periodontitis-estadio-iv )
    * Chapple I, Time to take gum disease seriously.

LinkDaddy Announces Keyword Backlinks Marketing Service for Higher SERP Ranking

Retrieved on: 
Wednesday, March 27, 2024
NAP, Tier 1, Social media, Research, Tier 2, Address, Overalls

LinkDaddy announces its aggressive Tier 1 backlinks service, helping businesses to improve their positioning in search engine results pages.

Key Points: 
  • Recent marketing research shows that backlinks still play a key role in overall visibility.
  • LinkDaddy's Tier 1 service takes a multi-faceted approach to building high-quality backlinks.
  • Tony Peacock, the agency founder, states: "Get high-quality backlinks that help you to increase organic traffic and improve search engine rankings.
  • With our services, you can make your business more visible online with press releases, Google profile marketing, and social media management services."

Imugene's oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024

Retrieved on: 
Tuesday, April 9, 2024
HER2, CD8, Phosphorylation, Survival, Cholangiocarcinoma, Immunotherapy, RECIST, Oncology, MAST, Patient, City, Degranulation, ASX, ADCC, Cancer, Hope, Overalls, Pembrolizumab, PRS, AACR, SPECT, Vaccination, Melanoma, Recurrence, PD-L1, IMU, Medical imaging

Oncolytic virus CF33-hNIS (VAXINIA) alone or in combination with KEYTRUDA is a safe treatment option for advanced cancer patients.

Key Points: 
  • Oncolytic virus CF33-hNIS (VAXINIA) alone or in combination with KEYTRUDA is a safe treatment option for advanced cancer patients.
  • SYDNEY, Australia, April 09, 2024 (GLOBE NEWSWIRE) -- Imugene Limited (ASX: IMU), a clinical stage immuno-oncology company, is pleased to announce poster presentations featuring its CF33 oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx at the American Association for Cancer Research (AACR) Annual Meeting 5-10 April 2024, in San Diego, CA.
  • HER-Vaxx induced HER2-specific antibodies able to mediate antibody-dependent cell cytotoxicity (ADCC) and inhibit intracellular HER2 phosphorylation and correlated with tumour reduction.
  • The HER-Vaxx induced HER2-specific antibodies demonstrate a similar mechanism of action to HERCEPTINâ validating B cell immunotherapy as an alternative anti-cancer agent to monoclonal antibodies.

Jamf Event showcases product innovations aimed at helping organizations meet security and compliance needs

Retrieved on: 
Tuesday, April 9, 2024
Microsoft, IPad, Comparison, Organization, Apple, IPhone, IPadOS, Environment, Mac, Education, MacOS, JAMF, Overalls, Educational technology, Computer, Telemetry, Microsoft Teams, WatchOS, Privacy, IOS, CIS

Compliance Editor with Jamf Pro for iOS and iPadOS removes ambiguity around enforcing compliance on mobile devices - Compliance Editor is the tool that generates deployable configuration files in Jamf Pro that allow organizations to meet CIS benchmarks.

Key Points: 
  • Compliance Editor with Jamf Pro for iOS and iPadOS removes ambiguity around enforcing compliance on mobile devices - Compliance Editor is the tool that generates deployable configuration files in Jamf Pro that allow organizations to meet CIS benchmarks.
  • Jamf announced Compliance Editor is now available for iOS and iPadOS, ensuring consistent security benchmarks can be met across Mac, iPhone and iPad.
  • Jamf Routines in Jamf Pro make powerful self-healing workflows a reality - Jamf announced Jamf Routines, which offers Jamf Pro customers new no-code automations and integrations to make IT teams more powerful and efficient.
  • With Jamf Routines, admins can also specify when a re-deploy of the Jamf Management Framework may be required to get devices back into compliance, improving overall security and compliance posture.

Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing

Retrieved on: 
Tuesday, April 9, 2024
MYGN, Genetics, Overalls, Medicine, Patient, Myriad Genetics, Cohort (statistics), Genetic testing, DSM-IV codes, Pharmaceutical industry

(NASDAQ: MYGN), a leader in genetic testing and precision medicine, revealed results from a multi-year, real-world study of nearly 21,000 patients that indicated those with major depressive disorder had reduced healthcare utilization after taking the GeneSight® Psychotropic test .

Key Points: 
  • (NASDAQ: MYGN), a leader in genetic testing and precision medicine, revealed results from a multi-year, real-world study of nearly 21,000 patients that indicated those with major depressive disorder had reduced healthcare utilization after taking the GeneSight® Psychotropic test .
  • “We are encouraged by the initial results of this study that showed how the proportion of patients with hospitalizations was significantly reduced after GeneSight testing,” said Dale Muzzey, chief scientific officer, Myriad Genetics.
  • We expect to share additional study results later this year.”
    The study demonstrated that the percentage of patients with hospitalizations was significantly reduced 180 days after GeneSight testing:
    39% relative reduction in psychiatric-related hospitalizations.
  • Significant reduction in hospitalizations for patients who were switched to a medication with no or moderate gene-drug interactions.

SUGi Creates NYC’s First Miyawaki Method Pocket Forest in Collaboration with iDig2Learn, Roosevelt Island Operating Corporation and the Lenape Center on Roosevelt Island

Retrieved on: 
Monday, April 8, 2024
Community, SUGi, Health, Climate change, Organization, Growth, Nutrient, Entrepreneurship, Partnership, Natural Resources, Education, RIOC, Reuse, Tree, Overalls, Life, Biodiversity, City, Plant, Ecosystem, Green-Wood Cemetery, Soil, Collection, Forestry

This unique method of planting, known as the "Miyakwaki Method,"  creates dense, biodiverse forests that improve climate resilience and overall ecological sustainability in the areas where they are planted.

Key Points: 
  • This unique method of planting, known as the "Miyakwaki Method,"  creates dense, biodiverse forests that improve climate resilience and overall ecological sustainability in the areas where they are planted.
  • Community and collaboration — of plants and people — is crucial to resilience, healing, and growth; here, we couldn’t have asked for more,” stated Elise Van Middelem, Founder & CEO SUGi.
  • "We are excited to be a part of this pioneering project to mitigate flooding and enhance biodiversity," said Mary Cunneen, Acting-Chief Operating Officer for the Roosevelt Island Operating Corporation.
  • Lenape Center supports projects to restore and regenerate the ecosystem of our territory," shared Executive Director and Co-Founder, Joe Baker.

Leading National Massage Experience Squeeze Appoints Brian Boucher as Chief Operating Officer

Retrieved on: 
Monday, April 8, 2024
Partner, Culture, Organization, Planet Fitness, Overalls, Operating partner, Massage

Nashville, TN, April 08, 2024 (GLOBE NEWSWIRE) -- Squeeze , the fast growing massage experience from the founders of Drybar, announced today that Brian Boucher has been named the company’s Chief Operating Officer (COO), effective immediately.

Key Points: 
  • Nashville, TN, April 08, 2024 (GLOBE NEWSWIRE) -- Squeeze , the fast growing massage experience from the founders of Drybar, announced today that Brian Boucher has been named the company’s Chief Operating Officer (COO), effective immediately.
  • Bringing more than 20 years of operations experience to Squeeze, Boucher will oversee the company’s operational efficiencies to drive brand growth, in addition to implementing new initiatives to support Squeeze’s best-in-class franchise system.
  • "We are thrilled to welcome Brian as our newly appointed COO,” said Brittany Driscoll, Squeeze Co-Founder & CEO.
  • Brian Boucher is succeeding David Werner, who will be transitioning into the role as Squeeze’s Chief Product Officer.

TRUGOLF RELEASES GROUNDBREAKING E6 APEX RANGE TRAINING SOFTWARE AND SIGNS JOE HALLETT, PGA COACH OF THE YEAR

Retrieved on: 
Monday, April 8, 2024
CONNECT, APOGEE, Golf, Partnership, State, Overalls, APEX, Student, Human voice, Data, Lighting, PGA, Golf Digest, Video game

Released March 28, 2024, this first phase features stunning graphic fidelity and delivers a robust training experience that augments the popular E6 CONNECT.

Key Points: 
  • Released March 28, 2024, this first phase features stunning graphic fidelity and delivers a robust training experience that augments the popular E6 CONNECT.
  • “TruGolf is setting the new standard for modern golf with E6 APEX’s jaw-dropping cinematic visuals, and customizable environments,” said TruGolf Vice President of Marketing, Mason Jones.
  • Hallett and Chuck have teamed up with TruGolf to create brand-new content specifically designed for TruGolf simulation software that will be incorporated into E6 APEX in the near future.
  • Now, E6 users have professional grade tools to visualize, quantify, and analyze their game - turning every swing into an insight.